Collagen News and Research

Latest Collagen News and Research

Positive data from Cardium Therapeutics' Matrix Phase 2b Excellarate trial

Cardium Therapeutics today reported positive data from its Matrix Phase 2b clinical trial of Excellarate(TM) for the potential treatment of patients with chronic non-healing diabetic foot ulcers based on the Company's Gene Activated Matrix (GAM) technology platform.

15 Oct 2009

Medtronic announces results of study comparing INFUSE Bone Graft to autogenous bone graft

Medtronic, Inc. today announced results of a study comparing the safety and effectiveness of INFUSE® Bone Graft to autogenous bone graft (bone harvested from the patient) when used in maxillary sinus floor augmentation.

14 Oct 2009

Novasys Medical's Renessa named the most promising new product for 2009

Novasys Medical, Inc., a developer of innovative therapies in women's health, announced today that its Renessa® non-surgical treatment for female stress urinary incontinence (SUI) was inducted into the Phoenix Hall of Fame as the 2009 Most Promising New Product at the Phoenix Medical Device and Diagnostic Conference for Chief Executive Officers.

14 Oct 2009

Systagenix Wound Management forms new global Medical Advisory Board

Systagenix Wound Management has announced the formation of a new global Medical Advisory Board, consisting of a group of multi-disciplinary and highly respected wound care clinicians and practitioners from North America and Europe, which will be led by Systagenix's newly appointed Medical Director, Dr Robert Snyder.

13 Oct 2009

VirtualHealth Technologies, Wound Care Innovations enter licensing agreement to use Cifra healthcare platform

VirtualHealth Technologies, Inc., a provider of secure technology for electronic health records and connectivity for web-based healthcare solutions, announced today that its subsidiary Secure eHealth has entered into an agreement with Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies Inc., to use its Cifra secure healthcare platform.

12 Oct 2009

Cifra healthcare platform from Wound Management Technologies

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today that its subsidiary Wound Care Innovations, LLC has launched the Cifra(TM) healthcare platform to securely exchange and store information for ongoing evidence based case studies on its patented collagen CellerateRx® products in managing all types of wound care.

12 Oct 2009

New technique may lead to more effective treatment for liver disease

A combination of bioengineering and medical research at the University of California, San Diego has led to a new discovery that could pave the way for more effective treatments for liver disease.

12 Oct 2009

Renaissance Laser and Vein Institute offers the new Titan Procedure for firming up sagging skin

The Renaissance Laser and Vein Institute offers patients the new Titan Procedure to treat stretch marks and sagging skin like never before. Thanks to recent advances in laser technology, there is a new wave of impressive skin care lasers in the dermatological and cosmetic skin care world. Among this new wave of highly effective laser treatments is the Titan Procedure.

7 Oct 2009

CryoValve SG aortic human heart valve receives Humanitarian Use Device designation

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has received a Humanitarian Use Device (HUD) designation from the Food and Drug Administration (FDA) for its CryoValve® SG aortic human heart valve.

6 Oct 2009

Sit-and-reach test to gauge age-related arterial stiffness

How far you can reach beyond your toes from a sitting position - normally used to define the flexibility of a person's body - may be an indicator of how stiff your arteries are.

6 Oct 2009

Levels of vitamin C higher in fruit juices than specified on labels

A team of pharmacists from the University of Santiago de Compostela (USC) has established that the levels of vitamin C in many fruit juices and soft drinks are far higher than those indicated on their labels by the manufacturers. This finding has been possible owing to a new technique developed by the researchers to determine the content of vitamin C in these kinds of drinks.

5 Oct 2009

Myocardial and neurological effects of Tβ4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on the results of several important research programs with Thymosin beta 4 (Tβ4) presented at the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

5 Oct 2009

PDT-PCI combination with ENVIRON Surgical Roll-CIT effective for treating facial acne scars

The appearance of facial acne scars showed greater improvement with a combination treatment of photodynamic therapy (PDT) and percutaneous collagen induction (PCI or medical needling) with the ENVIRON® Surgical Roll-CIT(TM) compared to PDT alone.

5 Oct 2009

Clinical study data of Thymosin beta 4 presented

REGENERX BIOPHARMACEUTICALS, INC. today reported on several clinical studies with Thymosin beta 4 (Tβ4) presented the Second International Symposium on Thymosins in Health and Disease, in Catania, Italy.

3 Oct 2009

TriPollar technology effective in reducing stretch marks

Dr. Worophong Manuskiatti has been invited to present results of his study "Treatment of striae distensae in skin phototypes IV-V with a TriPollar radiofrequency device" in the upcoming meeting of the European Academy of Dermatology and Venereology (EADV) Conference held on October 7-10, 2009 in Berlin, Germany.

1 Oct 2009

Tβ4 therapy in EAE mice improves neurological functional recovery

REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers at the Henry Ford Health System in Detroit, Michigan, demonstrated for the first time that Tβ4 treatment of EAE (experimental autoimmune encephalomyelitis – an animal model for multiple sclerosis) significantly improves neurological functional recovery.

30 Sep 2009

Wound Management Technologies signs sales agreement with Med Pro Associates

Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today an agreement with Med Pro Associates of Colorado to serve as a non-exclusive independent sales and marketing representative to solicit sales, obtain orders and provide sales and marketing support for the company's line of products within the U.S.

30 Sep 2009

Preliminary results from procedural review of Menaflex released by the FDA

The U.S. Food and Drug Administration (FDA) yesterday released preliminary results of a review of its internal procedures surrounding the review of ReGen Biologics’Menaflex collagen meniscus implant for use in the U.S.

28 Sep 2009

Initial clinical results for Mpathy Medical's Omnisure sling released

Mpathy Medical, a rapidly growing medical device company which has developed and brought to market a range of less invasive surgical solutions used to restore pelvic health to women, released the initial clinical results for its newest product, Omnisure™, a novel full length sling for treatment of female stress urinary incontinence (SUI) at the American Urogynecologic Society’s (AUGS) Annual Meeting.

26 Sep 2009

Wound Management Technologies inks marketing agreement with Pharma Technology International

Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today an agreement with Pharma Technology International, LLC (Pharma Tech) to market, distribute and sell the company's wound care products in the Middle East. Pharma Tech is a joint venture between A&Z Pharmaceutical and BioPharma Management Technologies, Inc., a company recently acquired by Wound Management Technologies.

25 Sep 2009